Change over period: —
NSE · SENORES
SENORES
-29.6% from the 52-week high · +53.8% above the low
Senores Pharmaceuticals Ltd develops, manufactures, and markets a wide range of pharmaceutical products. The company focuses on tablets, capsules, injectables, and healthcare formulations, catering to domestic and international markets. It emphasizes quality, regulatory compliance, and research-driven product development to support better patient outcomes.
The short version. SENORES reported revenue of ₹192 crore for Sep 2026, up 18.5% from a year earlier. Net profit was ₹39 crore (up 21.9% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 45.82% in Sep 2026, up 0.05 points over 8 quarters.
1 · The price
How has the stock traded?
SENORES trades 29.6% below its 52-week high and 53.8% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹192 cr.
Sep 2026 net profit of ₹39 cr.
0.5 pts higher than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 192 | 180 | 175 | 175 | 162 | 138 | 114 | 103 |
| Net profit | 39 | 31 | 37 | 32 | 32 | 20 | 18 | 17 |
| Net margin % | 20.5 | 17.0 | 20.9 | 18.1 | 20.0 | 14.3 | 15.7 | 16.7 |
| EPS (₹) | 8.57 | 6.67 | 7.96 | 6.87 | 7.03 | 4.28 | 3.9 | 3.73 |
Annual
| FY2026 | FY2025 | |
|---|---|---|
| Revenue | 633 | 398 |
| Net profit | 122 | 58 |
| Net margin % | 19.2 | 14.6 |
| EPS (₹) | 26.39 | 12.67 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 13.0% in Mar 2026.
Profitability · 2 years
Returns and margins
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Return on equity % | 13.0 | 7.4 |
| Return on capital % | 15.6 | 9.3 |
| EBITDA margin % | 31.7 | 26.1 |
| Net margin % | 17.9 | 14.0 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Up 0.05 pts over 8 quarters.
Up 1.76 pts over 8 quarters.
Down 0.94 pts over 8 quarters.
+14 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 45.77 | 45.77 | 45.78 | 45.79 | 45.8 | 45.82 | 45.82 | 45.82 | +0.05 |
| FII | 4.25 | 4.17 | 3.67 | 4.28 | 3.35 | 3.64 | 6.62 | 6.01 | +1.76 |
| DII | 11.78 | 9.65 | 9.51 | 8.61 | 9.31 | 9.61 | 9.77 | 10.84 | -0.94 |
| Public | 38.2 | 40.4 | 41.04 | 41.31 | 41.54 | 40.93 | 37.79 | 37.33 | -0.87 |
Mutual fund holdings · Oct 2026
30 schemes hold this stock
16 the month before.
- Mahindra Manulife Large & Mid Cap Fund1.78% of NAV
- Bajaj Finserv Healthcare Fund1.65% of NAV
- Mahindra Manulife Innovation Opportunities Fund1.58% of NAV
- THE WEALTH COMPANY SMALL CAP FUND1.48% of NAV
- Bajaj Finserv Consumption Fund1.47% of NAV
- Mahindra Manulife Balanced Advantage Fund1.37% of NAV
- Bajaj Finserv Small Cap Fund1.13% of NAV
- SAMCO SPECIAL OPPORTUNITIES FUND1.04% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SENORES are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about SENORES
What is the SENORES share price?
SENORES (SENORES) last closed at ₹1,105.70, up 1.2% on the day. Its 52-week range is ₹710.25 to ₹1,550.90.
What is the market cap of SENORES?
SENORES has a market capitalisation of about ₹5,030 crore. Its price-to-earnings ratio is 37.3.
How are SENORES's latest results?
SENORES reported revenue of ₹192 crore for Sep 2026, up 18.5% from a year earlier. Net profit was ₹39 crore (up 21.9% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 45.82% in Sep 2026, up 0.05 points over 8 quarters.
Who owns SENORES?
As of Sep 2026, shareholding was: Promoter 45.82%, FII 6.01%, DII 10.84%, Public 37.33%.
How many mutual funds hold SENORES?
30 mutual fund schemes held SENORES in October 2026. That compares with 16 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.